{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:25:16Z","timestamp":1768249516443,"version":"3.49.0"},"reference-count":21,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition and Cancer"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1207\/s15327914nc4501_14","type":"journal-article","created":{"date-parts":[[2004,1,14]],"date-time":"2004-01-14T16:05:02Z","timestamp":1074096302000},"page":"124-131","source":"Crossref","is-referenced-by-count":11,"title":["Chronic DNA Damage and Niacin Deficiency Enhance Cell Injury and Cause Unusual Interactions in NAD and Poly(ADP-Ribose) Metabolism in Rat Bone Marrow"],"prefix":"10.1207","volume":"45","author":[{"given":"Jennifer C.","family":"Spronck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Pascale","family":"Bartleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann C.","family":"Boyonoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"p_1_675","unstructured":"Hoagland HC: Hematological complications of cancer chemotherapy. In The Chemotherapy Source Book, Perry MC (ed), Baltimore: Williams and Wilkins, 1992, pp 498-507."},{"key":"p_2_676","unstructured":"Tew KD, Colvin M, and Chabner BA: Alkylating agents. In Cancer Chemotherapy and Biotherapy, Chabner BA and Longo DL (eds), Philadelphia: Lippencott-Raven, 1996, pp 297-332."},{"key":"p_3_677","unstructured":"Tucker MA: Secondary cancers. In Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, and Rosenberg SA (eds), Philadelphia: JB Lippincott Co., 1993, pp 2407-2416."},{"key":"p_4_678","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jn\/130.5.1102","volume":"130","author":"Boyonoski AC","year":"2000","journal-title":"J Nutr"},{"key":"p_5_679","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jn\/132.1.108","volume":"132","author":"Boyonoski AC","year":"2002","journal-title":"J Nutr"},{"key":"p_6_680","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jn\/132.1.115","volume":"132","author":"Boyonoski AC","year":"2002","journal-title":"J Nutr"},{"key":"p_7_681","unstructured":"Chabner BA: Anticancer drugs. In Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, and Rosenberg SA (eds), Philadelphia: JB Lippincott Co., 1993, pp 325-417."},{"key":"p_8_682","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/7.5.745","volume":"7","author":"Gerson SL","year":"1986","journal-title":"Carcinogenesis"},{"key":"p_9_683","first-page":"1483","volume":"45","author":"Shisa H","year":"1985","journal-title":"Cancer Res"},{"key":"p_10_684","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01076101","volume":"122","author":"Lautier D","year":"1993","journal-title":"Mol Cell Biochem"},{"key":"p_11_685","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8257"},{"key":"p_12_686","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1021\/bi00189a012","volume":"33","author":"Satoh MS","year":"1994","journal-title":"Biochemistry"},{"key":"p_13_687","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/88.7.407","volume":"88","author":"Smith MA","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"p_14_688","doi-asserted-by":"crossref","unstructured":"Jacobson EL, Nunbhakdi-Craig V, Smith DG, Chen HY, Wasson BL, etal: ADP-ribose polymer metabolism: implications for human nutrition. In ADP-Ribosylation Reactions, Poirier GG and Moreau P (eds), New York: Springer-Verlag, 1992, pp 153-162.","DOI":"10.1007\/978-1-4419-8718-1_27"},{"key":"p_15_689","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/283593a0","volume":"283","author":"Durkacz BW","year":"1980","journal-title":"Nature"},{"key":"p_16_690","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jn\/124.9.1597","volume":"124","author":"Rawling JM","year":"1994","journal-title":"J Nutr"},{"key":"p_17_691","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1995.1245"},{"key":"p_18_692","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1998.2664"},{"key":"p_19_693","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4165(99)00054-9"},{"key":"p_20_694","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(95)02185-X"},{"key":"p_21_695","doi-asserted-by":"crossref","unstructured":"Bhatia M, Kirkland JB, and Meckling-Gill KA: Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells. Biochem J 308 Pt 1, 131-137, 1995.","DOI":"10.1042\/bj3080131"}],"container-title":["Nutrition and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1207\/S15327914NC4501_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T12:17:18Z","timestamp":1523103438000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.1207\/S15327914NC4501_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1207\/S15327914NC4501_14"],"URL":"https:\/\/doi.org\/10.1207\/s15327914nc4501_14","relation":{},"ISSN":["0163-5581","1532-7914"],"issn-type":[{"value":"0163-5581","type":"print"},{"value":"1532-7914","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}